Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

DISCLOSURE OF RIGHTS ATTACHED TO EQUITY SHARES

30th Apr 2020 07:00

RNS Number : 3144L
Impact Healthcare REIT PLC
30 April 2020
 

 

30 April 2020

Impact Healthcare REIT plc

(the "Company")

DISCLOSURE OF RIGHTS ATTACHED TO EQUITY SHARES

In compliance with Listing Rule 9.2.6ER(1), the Company has forwarded to the FCA a copy of its current Articles of Association, which is the document that sets out the terms and conditions attaching to its listed equity shares. A copy of the Articles of Association has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

Impact Health Partners LLP

Mahesh Patel

Andrew Cowley

via Maitland/AMO

Winterflood Securities Limited

Joe Winkley

Neil Langford

Tel: 020 3100 0000

RBC Capital Markets

Rupert Walford

Matthew Coakes

Tel: 020 7653 4000

Maitland/AMO (Communications Adviser)

James Benjamin

Tel: 020 7379 5151

Email: [email protected]

 

The Company's LEI is 213800AX3FHPMJL4IJ53.

 

Further information on Impact Healthcare REIT is available at www.impactreit.uk.

 

NOTES:

Impact Healthcare REIT plc is a real estate investment trust ("REIT") which aims to provide shareholders with an attractive return, principally in the form of quarterly income distributions and with the potential for capital and income growth, through exposure to a diversified portfolio of UK healthcare real estate opportunities, in particular care homes for the elderly. The Group's investment policy is to acquire, renovate, extend and redevelop high quality healthcare real estate assets in the UK and lease those assets primarily to healthcare operators providing residential healthcare services under full repairing and insuring leases.

 

The Group's Ordinary Shares were admitted to trading on the main market of the London Stock Exchange, premium segment, on 8 February 2019. The Company is a constituent of the FTSE EPRA/NAREIT index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
CIRSEMSUUESSELL

Related Shares:

Impact Health
FTSE 100 Latest
Value8,415.25
Change7.81